The Administrative Core A, led by the Project Director, Dr. Richard Wyatt, will provide general management and administrative support for all Projects 1-4 and Core B under the HIVRAD POl. Additionally, this Core will coordinate an administrative plan to maintain clear lines of communication with investigators and collaborators within the bounds ofthe HIVRAD. Furthermore, communication with advisory board members and interactions with external researchers with interests in the HlV-1 Env-based vaccines and the analysis of B cell responses elicited of selected HIV-1 envelope glycoproteins candidates will be facilitated.
The first Aim will be to establish a project management plan designed by the Program Director with the goal to ensure the success ofthe HIVRAD through the several steps including a) continuous monitoring ofthe scientific progress of each component ofthe program, b) encouraging and leading internal communications among the individual investigators at each institution c) informing the appropriate officials at NIH of progress via teleconferences or email summaries d) provide fiscal review to ensure that all financial resources are appropriately utilized and e) initiating collaborations with investigators not currently part of this program.
The second Aim of this Core will be to form of a Scientific Advisory Board (SAB) and schedule annual meetings to evaluate progress and success of this HIVRAD program project.
This Core will oversee the coordination of all the Projects and Cores designed to elicit broadly neutralizing antibodies to the human pathogen HIV-1 toward the goal of a broadly effective vaccine. Thereby, this Core will have a direct impact on the improvement of human public health.
|Karlsson Hedestam, Gunilla B; Guenaga, Javier; Corcoran, Martin et al. (2017) Evolution of B cell analysis and Env trimer redesign. Immunol Rev 275:183-202|
|Kwong, Peter D; Chuang, Gwo-Yu; DeKosky, Brandon J et al. (2017) Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1. Immunol Rev 275:108-128|
|Guenaga, Javier; Garces, Fernando; de Val, Natalia et al. (2017) Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein. Immunity 46:792-803.e3|
|Stano, Armando; Leaman, Daniel P; Kim, Arthur S et al. (2017) Dense Array of Spikes on HIV-1 Virion Particles. J Virol 91:|
|Martinez-Murillo, Paola; Tran, Karen; Guenaga, Javier et al. (2017) Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach. Immunity 46:804-817.e7|
|Wang, Yimeng; O'Dell, Sijy; Turner, Hannah L et al. (2017) HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. J Virol 91:|
|Bale, Shridhar; Goebrecht, Geraldine; Stano, Armando et al. (2017) Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses. J Virol 91:|
|Ingale, Jidnyasa; Stano, Armando; Guenaga, Javier et al. (2016) High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells. Cell Rep 15:1986-99|
|Longo, Nancy S; Sutton, Matthew S; Shiakolas, Andrea R et al. (2016) Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding. J Virol 90:10574-10586|
|Wang, Yimeng; Sundling, Christopher; Wilson, Richard et al. (2016) High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence. J Immunol 196:3729-43|
Showing the most recent 10 out of 33 publications